The rising geriatric population to boost the Varicose Veins Treatment Market growth

 

Varicose Vein Treatment Market
Varicose Veins Treatment Market 

The Varicose Veins Treatment Devices Market is segmented by Treatment Type (Endovenous Ablation, Injection Sclerotherapy, and Surgical Ligation/Stripping), Product (Ablation Devices (Radiofrequency Ablation Devices and Laser Ablation Devices), Venous Closure Products, and Surgical Products), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

The global Varicose Veins Treatment Market is estimated to be valued at US$ 1,273.0 million in 2022 and is expected to exhibit a CAGR of 6.5% during the forecast period (2022-2030).

Market Overview:

Varicose veins are perverted, inflated veins. Any vein that is nearer to the skin's surface can become varicose. Varicose veins generally impact the veins in the lower extremities. That's because standing and walking rises the burden in the veins of the lower extremity.

Competitive Landscape:

Key players involved in the x are Quanta System, Medtronic plc, AngioDynamics Inc., Syneron Medical Ltd, Biolitec AG, Teleflex incorporated, Lumenis, and Vascular Solutions Inc.

Market Key Drivers:

The rising geriatric population is expected to augment the growth of the global varicose veins treatment market. For instance, as per WHO, around 80% of the population would be geriatric by 2050.

The rising incidence of varicose veins is projected to propel the growth of the global varicose veins treatment market.  For instance, as per a report by BMC Nursing in February 2020, varicose veins are known to be one of the most chronic venous diseases, distressing 20-60% of all adults across the globe.

Covid-19 Impact Analysis:

The outbreak of COVID-19 is has adversely affected the growth of global varicose veins treatment market. As the concentration of hospital staff and doctors has been transferred towards the therapy of COVID-19-infected patients. Hence, the treatment of non-emergency medical problems was given less priority which impeded the market growth.

Key Takeaways:

The global varicose veins treatment market is expected to exhibit a CAGR of XX % during the forecast period due rising investments, acquisitions and launches. For instance In May 2022, THERACLION, has introduced SONOVEIN HD. This method gathers SuperSonic Imagine's cutting-edge imaging abilities with the initial and only extracorporeal therapeutic ultrasound method.

Among region North America, Asia Pacific and Europe are anticipated to witness robust growth in the global varicose veins treatment market due to rising incidences of varicose veins, increasing adoption and quick product launches. For instance, as per Clinical Epidemiology and Global Health in December 2021, varicose veins affect around 23% of people in U.S.

Comments

Post a Comment

Popular posts from this blog

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular t...
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories ...
Read more

Organic Milk Has Much Higher Concentration Of Iron, Vitamin E, And Polyunsaturated Fatty Acids Omega-3 And Omega-6 As Compared To Regular Milk

Image
  Organic Milk Organic Milk is milk made from livestock raised using organic farming practices. The use of the term "organic" is regulated by food authorities in most jurisdictions. Organic cows are not allowed to be given hormones, which stimulate milk production. Organic feed also must be grown without the use of synthetic pesticides. Organic cows must get a certain percentage of their diet from grazing, although most organic dairies supplement the grass with grain. However, organic grazing cows produce less milk than cows that eat a grain-based diet. Buying organic milk may be a better investment for your health. According to Coherent Market Insights the Organic Milk Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. The standards for organic milk are stringent. To meet the organic standard, a dairy farm cannot use any form of animal growth hormones or antibiotics. Organic cows must spend at least 30% of their lives on pasture. C...
Read more